Fundraising Fox

Edge Therapeutics

Berkeley Heights, US · Delaware corporation · 1 known investors

Hospital-based therapies for acute, life-threatening neurological conditions. (NASDAQ: EDGE)

Biotech

Founders & leadership

RL
Robert Loch MacdonaldCo-founder
BA
Brian A. LeuthnerCo-founder
AE
Andrew EinhornExecutive
AN
Albert N. Marchio IIExecutive
HJ
Herbert J. FaleckExecutive
CJ
Carl J. SorannoNamed on SEC filing

Board

IB
Isaac BlechBoard director
JL
James LoughlinBoard director
RS
Robert SpiegelBoard director
KC
Kurt ContiBoard director
SJ
Sol J. BarerBoard director

Investors · 1

Sofinnova VenturesMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements

$63.9M disclosed across 2 rounds · 2014–2015

▶$56MraisedApr 2015 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew EinhornExecutive Officer
  • James LoughlinDirector
  • Isaac BlechDirector
  • Albert N. Marchio IIExecutive Officer
  • Robert SpiegelDirector
  • Kurt ContiDirector
  • Robert Loch MacdonaldExecutive Officer, Director
  • Herbert J. FaleckExecutive Officer
  • Sol J. BarerDirector
  • Carl J. SorannoExecutive Officer
  • Brian A. LeuthnerExecutive Officer, Director
Offering amount
$56M
Amount sold
$56M
Finders' fees
$3.3M
Placement agents
Credit Suisse Securities (USA) LLC, Leerink Partners LLC, Maxim Group, LLC
First sale
Apr 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.9MraisedNov 2014 · 104 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Albert N. Marchio IIExecutive Officer
  • Robert Loch MacdonaldExecutive Officer, Director
  • Robert SpiegelDirector
  • Carl J. SorannoExecutive Officer
  • Brian A. LeuthnerExecutive Officer, Director
  • James LoughlinDirector
  • Herbert J. FaleckExecutive Officer
  • Sol J. BarerDirector
  • Andrew EinhornExecutive Officer
  • Isaac BlechDirector
  • Kurt ContiDirector
Offering amount
$25M
Amount sold
$7.9M
Minimum investment
$10K
Sales commissions
$595.9K
Placement agents
Maxim Group LLC
First sale
Nov 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Edge Therapeutics Raises $72.5M in Funding - FinSMEsfinsmes.com · Apr 2015Edge Therapeutics Raises $72.5 Million Through Successive Series C-1 and C-2 Financings - Proceeds to Advance Development of EG- | Fierce Biotechfiercebiotech.com · Apr 2015

Frequently asked questions

What does Edge Therapeutics do?
Hospital-based therapies for acute, life-threatening neurological conditions. (NASDAQ: EDGE)
Who founded Edge Therapeutics?
Edge Therapeutics was founded by Robert Loch Macdonald, Brian A. Leuthner.
Who are Edge Therapeutics's investors?
Edge Therapeutics's investors include Sofinnova Ventures.
How much funding has Edge Therapeutics raised?
Edge Therapeutics has disclosed $63.9M raised across 2 rounds.
Where is Edge Therapeutics headquartered?
Edge Therapeutics is headquartered in Berkeley Heights, US.